Jens Ersbøll

RISK OF THERAPY-RELATED LEUKAEMIA AND PRELEUKAEMIA AFTER HODGKIN'S DISEASE

J Pedersen-Bjergaard, Severin Olesen Larsen, J. Struck et al. · The Lancet · 1987 · 223 citations

Medicine, Oncology, Cancer Epidemiology +8

A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-hodgkin's lymphomas

Nis I. Nissen, Jens Ersbøll, Hanne Sand Hansen et al. · Cancer · 2006 · 197 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Carcinoma of the Urinary Bladder after Treatment with Cyclophosphamide for Non-Hodgkin's Lymphoma

J Pedersen-Bjergaard, Jens Ersbøll, V.L. Hansen et al. · New England Journal of Medicine · 1988 · 196 citations

Medicine, Oncology, Urology +12

Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.

J Pedersen-Bjergaard, Preben Philip, Larsen So et al. · PubMed · 1993 · 182 citations

Medicine, Hematology, Oncology +17

Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma

Francesco Pezzella, Margaret T. Jones, Jens Ersbøll et al. · British Journal of Cancer · 1992 · 97 citations · Full text

Medicine, Oncology, Pathology +16